A few news items of interest this week:
Hormone trials: you win some (Wyeth), and you lose some (Pfizer).
AstraZeneca gets approval for once-daily Seroquel.
Sanofi’s Lovenox gets an expanded indication.
Sepracor: changes at the top.
Diabetes meds – about to explode in usage? Most likely…
Leave a Reply